Journal article
Linzagolix, with and without add-back therapy, in women with endometriosis-associated pain: results from EDELWEISS 6, a double-blind randomized extension and withdrawal study
- Abstract:
-
STUDY QUESTION: Was the efficacy of linzagolix, observed at 6 months in women with endometriosis-associated pain, maintained when administered for an additional 6 months? SUMMARY ANSWER: Efficacy from this extension study complements the results of the main trial, by showing that linzagolix is effective at reducing endometriosis-associated pain for a majority of women. WHAT IS KNOWN ALREADY: In the pivotal EDELWEISS 3 randomized controlled trial, the efficacy and safety of 24 weeks of once-da...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 2.3MB, Terms of use)
-
- Publisher copy:
- 10.1093/hropen/hoag030
Authors
- Publisher:
- Oxford University Press
- Journal:
- Human Reproduction Open More from this journal
- Volume:
- 2026
- Issue:
- 2
- Pages:
- hoag030
- Article number:
- hoag030
- Publication date:
- 2026-04-08
- Acceptance date:
- 2026-04-02
- DOI:
- EISSN:
-
2399-3529
- ISSN:
-
2399-3529
- Language:
-
English
- Keywords:
- Source identifiers:
-
4008921
- Deposit date:
-
2026-05-02
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record